Premium
Discovery of 7‐Methyl‐10‐Hydroxyhomocamptothecins with 1,2,3‐Triazole Moiety as Potent Topoisomerase I Inhibitors
Author(s) -
Xu Xiguo,
Wu Yuelin,
Liu Wenfeng,
Sheng Chuanquan,
Yao Jianzhong,
Dong Guoqiang,
Fang Kun,
Li Jin,
Yu Zhiliang,
Min Xiao,
Zhang Huojun,
Miao Zhenyuan,
Zhang Wannian
Publication year - 2016
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/cbdd.12767
Subject(s) - camptothecin , moiety , natural product , chemistry , topoisomerase , triazole , click chemistry , stereochemistry , drug discovery , combinatorial chemistry , enzyme , biochemistry , organic chemistry
Homocamptothecin is emerging as an important topoisomerase I inhibitor originating in natural product camptothecin. We report the modifications and SAR of homocamptothecin on position C 10 to develop potent topoisomerase I inhibitors for anticancer drug discovery. Based on click chemistry, twenty‐one 1,2,3‐triazole‐substituted homocamptothecin derivatives were readily synthesized in two steps. For A 549, cycloalkyl‐ and alkyl‐substituted compounds 6j , 6l , and 6o revealed highly antiproliferative inhibitory activities with IC 50 value of 30, 30, and 50 n m , respectively. In addition, cyclopropyl 6j exhibited greater T opo I inhibitory activity than 20( S )‐Camptothecin, which indicated suitability for further drug development.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom